Condition

Ovary Cancer clinical trials and research

• 18Clinical trials
• 1New in 30 days
• 7Countries

Newest Ovary Cancer clinical trials

All recruiting trials (18)

• One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy

  This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07895212

• INSPIRE: Putting patient-reported info into multidisciplinary tumor boards

  This study tests whether adding electronic patient-reported outcomes to tumor board discussions can help guide treatment decisions for women with breast, gynecologic, pancreatic cancers and related cancers.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama and 2 other locations · NCT07671937

• Ipalotinib and Sunitinib with Olaparib before surgery for HRD-positive advanced ovarian cancer

  This trial tests a neoadjuvant therapy combo in HRD-positive advanced ovarian cancer to see if it helps shrink tumors before surgery.

  Recruiting Phase 2 Anhui Provincial Cancer Hospital · Hefei · NCT07667751

• Avoiding a stoma after rectosigmoid surgery for advanced ovarian cancer

  This trial tests whether avoiding a protective stoma after rectosigmoid resection is safe for people undergoing cytoreductive surgery for advanced ovarian cancer.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07213193

• Short videos about genetic testing for ovarian and endometrial cancer patients

  This pilot will see if watching short English or Spanish videos helps patients with ovarian or endometrial cancer get genetic testing and referrals.

  Recruiting UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07084168

• Assessing whole-body metabolism in ovarian cancer patients

  This study is testing how ovarian cancer affects fat metabolism in women before, during, and after their treatment to see if it can help find new ways to treat the disease.

  Recruiting University of Tennessee Graduate School of Medicine · Knoxville, Tennessee · NCT06800105

• Using FRD001 to improve ultrasound imaging for ovarian cancer detection

  This study is testing if an injection called FRD001 can make ultrasound imaging better at telling the difference between harmless and cancerous ovarian growths in women.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06556342

• Disitamab vedotin (RC48) with AK104 and bevacizumab for recurrent or persistent clear cell ovarian cancer

  This trial tests whether combining a HER2-targeted antibody–drug conjugate (disitamab vedotin) with the PD-1/CTLA-4 bispecific AK104 and bevacizumab helps people with recurrent or persistent ovarian clear cell carcinoma.

  Recruiting Phase 2 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guanzhou, Guangdong · NCT06540729

• Evaluating CT features in ovarian cancer for AI model development

  This study is testing if certain CT scan features in women with advanced ovarian cancer can help create an AI model to predict surgery success and chemotherapy response.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT06331130

• Using tart cherry juice to prevent nerve damage from chemotherapy in breast cancer patients

  This study is testing if drinking tart cherry juice can help prevent nerve damage in breast cancer patients receiving chemotherapy.

  Recruiting Phase 2 University of California, Davis · Sacramento, California · NCT06268665

• Evaluating a new CAR T-cell therapy for solid tumors expressing MSLN

  This study is testing a new CAR T-cell therapy to see if it can safely treat adults with solid tumors like colorectal and lung cancer that express a specific protein.

  Recruiting at 12 sites Phase 1/2 A2 Biotherapeutics Inc. · Gilbert, Arizona and 11 other locations · NCT06051695

• Fasting regimen for women undergoing chemotherapy after surgery for gynecologic cancers

  This study is testing if an alternate day fasting diet can help women with ovarian and endometrial cancers feel better during chemotherapy and improve their quality of life.

  Recruiting Northwestern University · Chicago, Illinois · NCT05990426

• Combination therapy using Mirvetuximab Soravtansine and Olaparib for ovarian cancer maintenance

  This study is testing a new combination treatment with Mirvetuximab Soravtansine and Olaparib to see if it helps women with certain types of recurrent ovarian cancer stay healthy after their initial treatment.

  Recruiting at 6 sites Phase 2 University of Colorado, Denver · Irvine, California and 5 other locations · NCT05887609

• Using blood tests to improve ovarian cancer diagnosis

  This study is testing whether a blood test that looks for tumor DNA can help doctors better tell if women with suspected ovarian cancer have a serious condition or not before they have surgery.

  Recruiting University of Aarhus · Aarhus · NCT05763511

• A network for collaborative cancer research in Ontario

  This study is testing a new way to improve cancer treatment by using genetics and technology to help personalize care for people with different types of cancer.

  Recruiting at 2 sites University Health Network, Toronto · Kingston, Ontario and 2 other locations · NCT05403177

• Infusion of engineered lymphocytes for patients with NY-ESO-1 expressing metastatic cancers

  This study is testing a new treatment using specially modified immune cells to see if it can help people with certain advanced cancers that have the NY-ESO-1 marker.

  Recruiting Phase 1/2 Hadassah Medical Organization · Jerusalem · NCT05296564

• Combination therapy using checkpoint inhibitors for advanced solid tumors

  This study is testing a new combination treatment using special antibodies for people with advanced solid tumors like lung and liver cancer to see if it can be safer and more effective than current options.

  Recruiting Phase 1/2 Second Affiliated Hospital of Guangzhou Medical University · Guangzhou, Guangdong · NCT05187338

• Adaptive chemotherapy approach for relapsed ovarian cancer

  This study is testing if adjusting the dose of carboplatin based on a blood marker can help women with relapsed ovarian cancer feel better and have fewer side effects from treatment.

  Recruiting Phase 2 University College, London · London · NCT05080556

Related topics

Quick answers

How many Ovary Cancer clinical trials are recruiting right now?

18, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in United States (7 trials), China (5 trials), Italy (2 trials), Denmark (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1/2: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →